NitroMed Inc. (NASDAQ: NTMD) today announced that it will present at the 24th Annual JPMorgan Healthcare Conference, being held January 9-12, at the Westin St. Francis Hotel in San Francisco, CA. Michael D. Loberg, Ph.D., NitroMed’s President and Chief Executive Officer, will present a corporate overview and BiDil(R) launch progress report on Monday, January 9, at 3:30 pm (PT).
